Indivior PLC is a specialty pharmaceutical company renowned for its development, manufacture, and commercialization of medications targeting addiction and serious mental health disorders. The company's primary function is to address the global epidemic of opioid dependence through innovative treatments, such as its well-known product for opioid addiction, which plays a critical role in healthcare systems worldwide. As a pioneer in opioid addiction treatment, Indivior impacts both the pharmaceutical industry and public health sectors by providing effective solutions to a growing societal challenge. Headquartered in Richmond, Virginia, Indivior operates on a global scale, emphasizing scientific research to produce evidence-based treatments. Its products are distributed across numerous countries, offering support to healthcare providers and patients. Indivior's significance in the market stems from its dedicated focus on addiction treatment, filling a vital niche that combines medical innovation with social responsibility, amid increasing demand for efficient healthcare interventions.